# FDA 483 - Baxter Healthcare Corporation - September 29, 2025

Source: https://www.keypedia.com/records/483/baxter-healthcare-corporation/41c73678-1e20-4dd5-91f3-6f98d27335d9

> FDA 483 for Baxter Healthcare Corporation on September 29, 2025. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Baxter Healthcare Corporation
- Inspection Date: 2025-09-29
- Product Type: drugs
- Office Name: New Orleans District Office
- Summary: This FDA Form 483 details significant deficiencies at Baxter Healthcare Corporation in Cleveland, MS, related to manufacturing and quality control. Observations include inadequate investigation of product contamination, unsound laboratory controls for sampling and testing, insufficient data backup, poor equipment maintenance leading to rust contamination, and structural issues in a cleanroom. These issues indicate a lack of robust quality systems that could impact drug product safety and purity.

## Related Documents

- [483 - 2010-02-05](https://www.keypedia.com/records/483/baxter-healthcare-corporation/91e4d650-b820-43f0-b18b-57a80024dd0b)
- [483 - 2014-01-23](https://www.keypedia.com/records/483/baxter-healthcare-corporation/1d37a3d1-2ecf-4af7-8e65-2244b554f457)
- [CRL - Unknown Date](https://www.keypedia.com/records/crl/baxter-healthcare-corporation/3bdc6528-7153-48aa-a07c-71c5c7310992)
- [WARNING_LETTER - 2023-01-27](https://www.keypedia.com/records/warning_letter/baxter-healthcare-corporation/3e82bbf1-a8b1-4f5d-b6c9-799df5b13d62)
- [CRL - Unknown Date](https://www.keypedia.com/records/crl/baxter-healthcare-corporation/e6764f6e-5764-455f-87ea-68e83b987ff4)

## Related Officers

- [Microbiologist](https://www.keypedia.com/people/camerson-e-moore/50733244-0d55-4b0b-a758-f192b7c66457)

Company: https://www.keypedia.com/companies/baxter-healthcare-corporation/738590ab-c241-4de1-aaec-722e154bfc45

Office: https://www.keypedia.com/offices/new-orleans-district-office/95352142-b992-4e06-849d-d7483c0959ea